As of June 13, 2025, Hims & Hers Health Inc (HIMS) reports a Gross Margin of 79.45%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Hims & Hers Health Inc's Gross Margin
Over recent years, Hims & Hers Health Inc's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-12-31 | 79.45% |
| 2023-12-31 | 81.99% |
| 2022-12-31 | 77.57% |
| 2021-12-31 | 75.22% |
This slight upward trend highlights how Hims & Hers Health Inc manages its operational efficiency and pricing power over time.
Comparing Hims & Hers Health Inc's Gross Margin to Peers
To better understand Hims & Hers Health Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Hims & Hers Health Inc (HIMS) | 79.45% |
| Biora Therapeutics Inc (PROG) | 100.00% |
| Castle Biosciences Inc (CSTL) | 81.87% |
| Biodesix Inc (BDSX) | 78.17% |
| Medical Marijuana Inc (MJNA) | 76.40% |
| Cannabis Sativa Inc (CBDS) | 65.86% |
Compared to its competitors, Hims & Hers Health Inc's Gross Margin is among the highest compared to peers, indicating superior product pricing power or cost efficiency in production.